生物活性 | |||
---|---|---|---|
描述 | LLY-507 is a potent and selective SMYD2 inhibitor with IC50 value <15nM, >100-fold selective for SMYD2 over a broad range of methyltransferase and non-methyltransferase targets. LLY-507 inhibited SMYD2-induced p53 methylation in U2OS cells with an IC50 of 0.6μM. Inhibition of SMYD2 by LLY-507 did not significantly affect cellular global histone methylation levels for SMYD2 targeted a very small subset of histones at specific chromatin loci and/or non-histone substrates. LLY-507 inhibited the proliferation of several esophageal, liver, and breast cancer cell lines in a dose-dependent manner, with IC50 values<10μM post 3 days or 7 days[2]. | ||
作用机制 | LLY-507 binds in the substrate peptide binding pocket.[2] |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.74mL 0.35mL 0.17mL |
8.70mL 1.74mL 0.87mL |
17.40mL 3.48mL 1.74mL |
参考文献 |
---|